The Global Flow Cytometry Market size was estimated to be US$ 4.7 billion in 2019. Flow cytometry is a diagnostic device utilized in the exploration and measurement of physical features of cells or particles. It has evolved as a vital device for exploratory and safety objectives during drug detection and advancement methods.
There is a prominence of flow cytometry in clinical research that is driving the demand for flow cytometry methods in R&D divisions of the healthcare sector. Furthermore, the growing occurrences of cancer and HIV numbers show a noteworthy unmet opportunity in AIDS and cancer diagnostics. There is a huge void in diagnostics convenience, mostly in the emerging regions. As a result, the growing numbers of HIV AIDS and cancer patients can be a substantial growth opportunity for the flow cytometry market.
Furthermore, the growing occurrence of chronic disorders, which require toxicity testing, and the necessity for fast, precise, and profound prognosis procedures for disease confirmation are anticipated to propel the demand for these procedures. Introduction of advanced methods, such as fast discovery, higher resolution, improved cell sorting, and high-throughput multifunctional analysis, safeguarding improved effectiveness in illustrating and recognizing new drugs is also anticipated to drive the market expansion.North America headed the flow cytometry market in 2019 due to the existence of helpful government restructurings for the growth of innovative technologies for molecular diagnostics. It likely to uphold dominance over the forecast years as a result of the accessibility of trained specialists and greater consciousness levels.
The United States is the highest market in North America thanks to the high occurrence of cancer and other chronic disorders. Likewise, the existence of a huge number of clinical research labs and major pharmaceuticals in the United States is expected to add to the country’s development.
The APAC region is anticipated to experience the rapid growth rate in the imminent year thanks to the reassuring government finance for the biotech business improvement. Additionally, the existence of unused opportunities, continuously refining healthcare substructure, accelerated financial growth, and growing patient consciousness levels are further estimated to accelerate the local market.
Incessant R&D projects for cancer cure in the region, facilitating the demand for cytometry, is further propelling the region’s market expansion. Besides, the increasing acceptance of new procedures for molecular-based cytogenetics, growing subcontracting ventures, and rising demand for initial diagnosis and recognition of illnesses will drive the market.
Flow Cytometry Market Share Analysis, by Geography (2022)
The report titled “Flow Cytometry Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Flow Cytometry Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global flow cytometry market is segmented on the basis of technology, product & services, application, end-use, and geography. Based on technology the market is segmented into cell-based and bead-based. By product & services the market is divided into instruments, reagent & consumables, software, accessories, and services. Depending on the application segment the flow cytometry market is divided into research, industrial, and clinical. On the basis of end-use the market is classified into commercial organizations, hospitals, academic institutes, clinical testing labs.
Based on geography, the global Flow Cytometry Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Indonesia, Australia, South Korea, Taiwan, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Flow Cytometry. Further, market share of prominent companies in the global Flow Cytometry Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Flow cytometry companies. The global Flow Cytometry Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the flow cytometry business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Flow Cytometry Market.
Major players active in the global flow cytometry market are GE Healthcare, Beckman Coulter, Inc., Stratedigm, Inc., Becton, Sysmex Corporation, Merck & Co., Inc., Luminex Corporation, Apogee Flow Systems Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Agilent Technologies, and Dickinson and Company.
Segmentation:
By Technology:
By Product & Services:
By Application:
By End-use:
By Region
The global Flow Cytometry market was worth US$ 4.7billion in 2020.
Major players operating in the global Flow Cytometry market include GE Healthcare, Beckman Coulter, Inc., Stratedigm, Inc., Becton, Sysmex Corporation, Merck & Co., Inc., Luminex Corporation, Apogee Flow Systems Ltd.
The end-use segments in Flow Cytometry market are Commercial, Organizations Hospitals, Academic Institutes and Clinical Testing Labs.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved